Letter: Considerations in the drug treatment of drug-induced and other acute dyskinesias.
D000293:Adolescent; D000978:Antiparkinson Agents / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy*; D010276:Parasympatholytics / Q000627:therapeutic use; D010622:Phencyclidine / Q000506:poisoning; D010640:Phenothiazines / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000978:Antiparkinson Agents; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010640:Phenothiazines; D014149:Tranquilizing Agents; D010622:Phencyclidine